内分泌干扰化合物、药品和个人护理产品（EDC/PPCP） 与对野生动物的各种不利影响有关。一些公共和监管机构 将饮用水中的EDC/PPCP化合物视为潜在的人类健康风险。杀虫剂和 除草剂可以是EDCs，自20世纪90年代以来，已在地表水和成品饮用水中检测到 20世纪70年代。然而，在过去的十年里，作为分析技术，检测每万亿水平的 有机化合物，许多工业生产的化学品已在成品中检测到 废水、工业废水、河流、饮用水源，甚至成品饮用水。 本文基于AwwaRF项目的台架试验结果 #2758.研究人员、顾问和公用事业公司将对这篇论文感兴趣，因为它 解决了新出现污染物的实际去除（在本研究中为67种目标化合物） 广泛的化学结构，并将有助于未来台架和中试规模试验的设计 用于评估EDC/PPC。在含有天然有机物和有机物的模型水中进行了小型试验 来自美国各地的四种天然水域。海水中加入了一套EDC/PPCP 化合物（初始浓度为50至500纳克/升）。每种水都加入了EDC/PPCP 复合混合物进行了几个平行的实验室规模处理，包括:明矾和铁 多pH水平下的凝固；化学软化（pH值9，>11）；氯化（SDS） 条件）；臭氧氧化（贾第虫失活水平，加上过氧化氢添加）； 活性炭吸附（2个PAC，在不同剂量下接触4小时）；死胡同 膜过滤（带负电/疏水性UF和NF膜）；还有生物方面 批量和柱状试验。 额外的紫外线光解试验和有限的生物降解试验 都是计划好的。采用LC-MS/MS和GC-MS/MS方法对该系列化合物进行分析。 使用氚（³H）标记的雌二醇与PAC进行补充实验 以及薄膜测试。试验和全面测试将在项目的后续阶段进行 这个项目。包括2个参考文献、表格和图表。

Endocrine-disrupting compounds, pharmaceuticals and personal care products (EDC/PPCPs) have been linked to a variety of adverse effects on wildlife. Some public and regulatory agencies view EDC/PPCP compounds in drinking water as a potential human health risk. Pesticides and herbicides can be EDCs and have been detected in surface and finished drinking waters since the 1970s. However, over the past decade as analytical techniques to detect parts-per-trillion levels of organic compounds, many industrial-produced chemicals have been detected in finished wastewater, industrial runoff, rivers, drinking water sources, and even finished drinking water. This paper is based upon results from bench-scale testing on an AwwaRF project #2758. Researchers, consultants, and utilities will be interested in this paper as it addresses actual removal of emerging contaminants (in this study 67 target compounds) spanning a wide range of chemical structures, and will aid in design of future bench and pilot-scale tests for evaluating EDC/PPCPs. Bench-scale experiments have been conducted in model waters with natural organic matter and four natural waters from around the United States. The waters were spiked with a suite of EDC/PPCP compounds (initial concentration of 50 to 500 ng/L). Each water spiked with the EDC/PPCP compound mixture was subjected to several parallel bench-scale treatments that include: alum and ferric coagulation at multiple pH levels; chemical softening (pH 9, >11); chlorination (SDS conditions); ozonation (Giardia inactivation levels, plus hydrogen peroxide addition); activated carbon adsorption (2 PACs with four hour contact times at various dosages); deadend membrane filtration (negatively charged/hydrophobic UF and NF membrane); and, biological batch and column tests. Additional UV-photolysis tests and limited biodegradation experiments are planned. LC-MS/MS & GC-MS/MS methods were used to analyze the suite of compounds. Supplemental experiments using tritium (³H) labeled estradiol were conducted with PAC and membrane tests. Pilot- and full-scale testing will be conducted during subsequent phases of the project. Includes 2 references, table, figures.